ArticleCureus2026
Clinico-Biochemical Profile and Outcomes in Young Adults With ST-Segment Elevation Myocardial Infarction at a Tertiary Care Hospital: An Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background ST-elevation myocardial infarction (STEMI) in young adults is increasingly recognized, with distinct risk factor profiles and potential differences in clinical outcomes compared to older patients. However, data from the Indian context remain limited, particularly regarding thrombolysis response. Objectives The aim of this study was to compare the clinical profile, risk factors, laboratory parameters, and outcomes of STEMI between young adults (≤45 years) and older patients (>45 years), with a focus on thrombolysis outcomes. Methods This prospective observational study included 60 patients with STEMI admitted to a tertiary care center over six months. Patients were categorized into young (≤45 years, n=16) and older (>45 years, n=44) groups. Clinical presentation, risk factors, laboratory parameters, electrocardiographic findings, thrombolysis characteristics, and outcomes were compared. Statistical analysis was performed using the chi-square test for categorical variables, with p<0.05 considered significant. Results Young adults constituted 16 (26.7%) cases and were predominantly male (45, 75.0%). Smoking was significantly more prevalent among younger patients (seven, 43.8% vs seven, 15.9%, p=0.024), while diabetes mellitus was more common in older patients (24, 54.5% vs four, 25.0%, p=0.042). Clinical presentation and ECG patterns were comparable between the groups. Younger patients had significantly higher white blood cell counts (11993.75 ± 3630.70 vs 9479.55 ± 2791.23 /µL, p=0.006) and platelet counts (312250 ± 75964.47 vs 261045.45 ± 60385.18 /µL, p=0.009). Despite similar door-to-needle times, successful thrombolysis was significantly lower among younger patients (seven, 43.8% vs 33, 75.0%, p=0.023). Overall clinical outcomes were comparable between the groups (p=0.227). Conclusion Young STEMI patients exhibit a distinct risk profile dominated by modifiable factors and demonstrate reduced thrombolysis success despite timely reperfusion, suggesting a heightened prothrombotic and inflammatory state. These findings underscore the importance of targeted prevention and support consideration of early invasive strategies in younger patients, warranting further large-scale studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.